Glenmede Investment Management’s Definitive Healthcare DH Stock Holding History

Glenmede Investment Management’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$126K	Buy	+31,019	New	+$124K	﹤0.01%	1323

Other funds holding DH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Investment Management's DH Position: Q3 2025 in Review

Glenmede Investment Management opened a new position in Definitive Healthcare (DH) in Q3 2025: 31,019 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #1323 among its holdings.

129 funds tracked by Wall St. Rank hold DH as of Q3 2025.

Glenmede Investment Management held 31,019 shares of Definitive Healthcare worth $126K as of Q3 2025.
Definitive Healthcare was a new Glenmede Investment Management position in Q3 2025.
Definitive Healthcare made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1323 holding.
129 funds tracked by Wall St. Rank held Definitive Healthcare as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.